Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The only visible update is a change in the site’s displayed revision version at the bottom of the page from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-24T06:33:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:50:32.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Replaced Padua, Italy, 35128 with Padova, Italy, 35128 to reflect the local official name.
    Difference
    0.0%
    Check dated 2026-04-09T21:47:03.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Systemic sclerosis was added as the disease term and Scleroderma removed where it referred to the same condition.
    Difference
    0.0%
    Check dated 2026-04-02T15:40:58.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Napoli, Italy 80138 was updated to Naples, Italy 80138 in the locations list.
    Difference
    0.0%
    Check dated 2026-03-26T11:44:10.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T04:49:01.000Z thumbnail image

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.